COVID-19 more severe with certain rheumatic diseases: study

Patients on biologics, but not conventional DMARDs, are also at increased risk, researchers say

Certain rheumatoid conditions and therapies are associated with higher risk for COVID-19, researchers say.

A study from Spain shows patients with spondyloarthritis, polymyalgia rheumatica or giant cell arteritis, and those on biologics and targeted-synthetic therapies, are at higher risk for hospital-diagnosed COVID-19 infection compared with the general population.

Data from more than 26,000 patients being treated at seven hospital rheumatology departments were checked for positive SARS-CoV